Search results for “Progonasyl” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 48 patents, we discovered top 25 key players by total patent application. Astellas Pharma, Inc., Novartis AG, F. Hoffmann-La Roche Ltd. are dominant in this area. They take 33.33% of the total patent filing.
Astellas Pharma, Inc.
Tokyo-to, Japan
Patent: 10
Novartis AG
Basel-Stadt, Switzerland
Patent: 3
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 3
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 3
Akebia Therapeutics, Inc.
Massachusetts, United States
Patent: 2
Tianjin Minxiang Biomedical Co., Ltd.
Tianjin Shi, China
Patent: 2
GlaxoSmithKline LLC
Pennsylvania, United States
Patent: 2
Bristol-Myers Squibb Holdings Ireland Unlimited Co.
Ireland
Patent: 2
Eli Lilly & Co.
Indiana, United States
Patent: 1
Mitsubishi Tanabe Pharma Corp.
Osaka-fu, Japan
Patent: 1
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 22 patents applied in the last 5 years. We discover 10 most active companies in this area. The fast-growing Astellas Pharma, Inc., Tianjin Minxiang Biomedical Co., Ltd., Akebia Therapeutics, Inc. take 63.64% of patent filing during this period.
Astellas Pharma, Inc.
Tokyo-to, Japan
Patent: 10
Tianjin Minxiang Biomedical Co., Ltd.
Tianjin Shi, China
Patent: 2
Akebia Therapeutics, Inc.
Massachusetts, United States
Patent: 2
Orion Ophthalmology LLC
New York, United States
Patent: 1
Commonwealth Scientific & Industrial Research Organisation
Australia
Patent: 1
Jiaxing University
Zhejiang Sheng, China
Patent: 1
Shanghai University of Traditional Chinese Medicine
Shanghai Shi, China
Patent: 1
Cangzhou Narui Chemical Technology Co., Ltd.
Hebei Sheng, China
Patent: 1
Mitsubishi Tanabe Pharma Corp.
Osaka-fu, Japan
Patent: 1
Harbin Normal University
Heilongjiang Sheng, China
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 22 patents in last 5 years, we discover 10 new entrants. Astellas Pharma, Inc., Tianjin Minxiang Biomedical Co., Ltd., Akebia Therapeutics, Inc. are the most active new entrants in this area.
Astellas Pharma, Inc.
Tokyo-to, Japan
Patent: 10
Tianjin Minxiang Biomedical Co., Ltd.
Tianjin Shi, China
Patent: 2
Akebia Therapeutics, Inc.
Massachusetts, United States
Patent: 2
Orion Ophthalmology LLC
New York, United States
Patent: 1
Commonwealth Scientific & Industrial Research Organisation
Australia
Patent: 1
Jiaxing University
Zhejiang Sheng, China
Patent: 1
Shanghai University of Traditional Chinese Medicine
Shanghai Shi, China
Patent: 1
Cangzhou Narui Chemical Technology Co., Ltd.
Hebei Sheng, China
Patent: 1
Mitsubishi Tanabe Pharma Corp.
Osaka-fu, Japan
Patent: 1
Harbin Normal University
Heilongjiang Sheng, China
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 5 patents, we discovered top 4 universities and scientific research institutions by total patent application. Nagoya Institute of Technology, Shanghai University of Traditional Chinese Medicine, Jiaxing University are dominant in this area. They take 60.00% of the total patent filing.
Nagoya Institute of Technology
Aichi-ken, Japan
Patent: 1
Shanghai University of Traditional Chinese Medicine
Shanghai Shi, China
Patent: 1
Jiaxing University
Zhejiang Sheng, China
Patent: 1
Harbin Normal University
Heilongjiang Sheng, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: